IMedis

AI-powered Quality Assurance Platform for Radiology

Startup

IMedis is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2018. AI-powered Quality Assurance Platform for Radiology. The company has raised a total of $3.7M across 3 funding rounds, currently at the Pre-Seed stage. IMedis was founded by Aviel Blumenfeld and Yitzi Pfeffer. Key investors include ExitValley, Sanara Ventures. The company has 500+ employees. Core technologies: Artificial Intelligence, Machine Learning, Computer Vision, Natural Language Processing.

With $3.7M in total funding, IMedis is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.

$3.7M
Raised
3
Rounds
2
Investors
3
Team
2018
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsArtificial IntelligenceMachine LearningComputer VisionNatural Language Processing
At a Glance
Investors
Founders
In the News

5 articles covered by sources including www.themarker.com, www.calcalistech.com, www.geektime.co.il.

www.themarker.com · Aug 15, 2021
צפו: הפיתוח הישראלי שמסייע לזהות מחלת סרטן בשלב מוקדם
Read article ↗
Frequently Asked Questions
What does IMedis do?

IMedis is developing a comprehensive quality management system for radiology departments. The AI-driven cloud-based solution aggregates and analyzes data from the PACS and RIS. By addressing failure points throughout the radiology workflow, IMedis aims to reduce risk, improve financial efficacy, and create new business opportunities. Duali-Q, IMedis's first commercially available module, allows management and follow-up of errors of omission in CT scans of the chest and the abdomen. Duali-Q was proven to increase detection rates of life-threatening diseases by 13% in a recent study and is now in use by teaching hospitals in the United States, United Kingdom, and Israel.

How much funding has IMedis raised?

IMedis has raised $3.7M in total funding across 3 rounds. The company is currently at the Pre-Seed stage. Key investors include ExitValley, Sanara Ventures.

Who founded IMedis?

IMedis was founded in 2018 by Aviel Blumenfeld (Co-founder & CEO), Yitzi Pfeffer (Co-founder & CTO).

What sector is IMedis in?

IMedis operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Artificial Intelligence, Machine Learning, Computer Vision, Natural Language Processing. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Where is IMedis located?

IMedis is based in Rehovot, Israel, Center District. The company also has offices abroad.

View Full Profile Classic View Website ↗